Eledon Pharmaceuticals, Inc. (ELDN) stock
ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.03+0.05 (+2.53%)
Close on Nov 18, 2026Market cap $164.96MP/E –Yield –
Eledon Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Eledon Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2016 was -$4.93M. For fiscal 2016 it was -$4.93M. The highest annual figure on record is -$4.93M in fiscal 2016.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | -$4.93M | – |
| FY2015 | Dec 31, 2015 | -$41.80M | – |
| FY2014 | Dec 31, 2014 | -$21.15M | – |
| FY2013 | Dec 31, 2013 | -$15.50M | – |
| FY2012 | Dec 31, 2012 | -$9.34M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2016 | Dec 31, 2016 | -$1.28M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.48M | – |
See a number that looks wrong?